why choose us

First received: July 24, 2023

Clinical Trial: Directed Topical Drug Delivery for Treatment for PASC Hyposmia

Study Status: Completed

Recruit Status: RECRUITING

Condition: Post Acute Sequelae Covid-19 Hyposmia

Study Type: INTERVENTIONAL


Official Title: Directed Topical Drug Delivery for Treatment for PASC Hyposmia

Brief Summary: This is a phase II randomized, double-blinded, placebo-controlled study to evaluate the efficacy of topical intranasal treatment of beclomethasone vs. placebo for improved olfactory function.

Read more